Collaborative Virtual Environment for Parkinson's (NCT07523425)
Comparing virtual reality for walking
- Trial ID
- NCT07523425
- Official Title
- COMPARATIVE EFFECTIVENESS of COLLABORATIVE VIRTUAL ENVIRONMENT and NON-IMMERSIVE VIRTUAL REALITY in the REHABILITATION of PATIENTS With PARKINSON'S DISEASE
- Goal
- Comparing virtual reality for walking
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Superior University
- Study Type
- INTERVENTIONAL
- Enrollment
- 60 participants
- Conditions
- Parkinson Desease
- Interventions
- Collaborative Virtual Environment, Non-Immersive Virtual Reality (NIVR)
Summary For Families
The goal is to find out whether a shared, therapist-guided virtual reality program or a standard screen-based virtual reality program does a better job of improving movement, thinking, walking, and overall quality of life for people with Parkinson's. Over 12 weeks both groups do goal-focused, repeatable exercises for arm coordination, walking, and balance; the collaborative program puts the patient and therapist in a shared virtual space for live guidance and feedback, while the other uses conventional screen-based tasks without that immersive, social interaction. The study is looking for men and women age 45 to 80 with mild to moderate Parkinson's (early to mid stages), who are on stable medication and do not have severe thinking problems (score 24 or higher on a common mental-status test). About 60 people will join, and anyone with severe vision, hearing, or other conditions that would prevent safe participation, a history of epilepsy, or a strong fear of virtual reality cannot take part.
Locations
- Punjab Institute of Neurosciences Lahore, Lahore, Punjab Province, Pakistan
Making Contact: How to Call This Study Site
Who to ask for
Ask for the study coordinator. Some sites call this person the research coordinator. They are the right person for questions about joining a study. If you reach a front desk or a doctor's office scheduler, ask them to connect you with the research team for this study.
What to say
It is fine to read this out loud, word for word:
Hello, my name is ____. I am calling about a Parkinson's study at your site. The study number is NCT07523425. It is the one about "Comparing virtual reality for walking". Could I speak with the study coordinator about taking part?
If you are calling for a family member, use their name and mention that you help with their care.
What they will ask you
- The year of diagnosis
- Current medications and their doses
- Other health conditions
- Any procedures already done, such as deep brain stimulation (DBS)
- How far you are able to travel for study visits
- Whether a care partner can come to visits with you
What to have ready
- A written list of current medications and doses
- Your neurologist's name and phone number
- The diagnosis date. The year is enough.
- A recent visit summary from the neurologist, if you have one
What to ask them
- How many visits are there, and how long does each visit take? The listing already answers this: The interventions are delivered over a 12-week period. Ask the coordinator to confirm it still applies.
- Is travel, parking, or my time reimbursed?
- Is there a placebo group, and what is my chance of being in it? The listing already answers this: There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another. Ask the coordinator to confirm it still applies.
- Would I need to stop or pause any of my current medications?
- What happens when the study ends? Could I stay on the treatment if it helps?
What to expect
- Expect to wait a few days for a callback. A week is common. Calling or emailing again after that is fine and normal.
- Many callers do not end up joining. Screening out is common and is not a judgment about you or your health.
- Asking questions commits you to nothing. You can stop the process at any point.
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Collaborative Virtual Environment. The goal is to find out whether a shared, therapist-guided virtual reality program or a standard screen-based virtual reality program does a better job of improving movement, thinking, walking, and overall quality of life for people with Parkinson's. Over 12 weeks both groups do goal-focused, repeatable exercises for arm coordination, walking, and balance; the collaborative program puts the patient and therapist in a shared virtual space for live guidance and feedback, while the other uses conventional screen-based tasks without that immersive, social interaction. The study is looking for men and women age 45 to 80 with mild to moderate Parkinson's (early to mid stages), who are on stable medication and do not have severe thinking problems (score 24 or higher on a common mental-status test). About 60 people will join, and anyone with severe vision, hearing, or other conditions that would prevent safe participation, a history of epilepsy, or a strong fear of virtual reality cannot take part.
- Who can participate?
- Participants must be between 45 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 4 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.
- How many visits does this trial involve?
- The interventions are delivered over a 12-week period.